# Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.

> **NCT06455553** · NA · COMPLETED · sponsor: **Centre Hospitalier Annecy Genevois** · enrollment: 48 (actual)

## Conditions studied

- Hematologic Malignancies
- Thrombopenia

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT06455553
- **Lead sponsor:** Centre Hospitalier Annecy Genevois
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-26
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455553, "Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06455553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*